Sabatolimab
novartis
['mds']
#eha22 #mdssm wiseman: sabatolimab (anti-tim3) appears well-tolerated and is showing deep responses in combo with aza. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)